DAKTARI DIAGNOSTICS, INC.

CAMBRIDGE, MA · Founded 2008 · CIK 0001470342 · Medtech · Defunct

Point-of-care diagnostic device for HIV viral load testing from whole blood samples

daktaridx.com →
Grants
$3.1M
8 awards
Sector median: 1
Raised
$34M
7 Form D · Mar 2015
138 months since last filing
Contracts
$63K
1 award · Defense
#558 of 4531 in medtech
Patents
20
3 granted · 17 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,547,254
Private capital raisedForm D · SEC$820,000
Private capital raisedForm D · SEC$1,800,000
Private capital raisedForm D · SEC$1,178,530
Private capital raisedForm D · SEC$4,999,987
Private capital raisedForm D · SEC$7,000,000
Federal grantDepartment of Health and Human Services · Phase II · Development of a Microfluidic Point-of-Care HCV Viral Load Assay$601,984
Private capital raisedForm D · SEC$15,499,999
Federal grantDepartment of Health and Human Services · Phase I · Self-assembling density gradients for sickle cell diagnosis in low resource areas$223,818
Federal grantDepartment of Health and Human Services · Phase II · Development of a Microfluidic Point-of-Care HCV Viral Load Assay$597,342
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · An HIV Viral Load Assay for the Point Of Care$649,572
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · An HIV Viral Load Assay for the Point-Of-Care$649,571
Federal contract· 1 of 2 same dayDepartment of Defense · Igf::ot::igf C152-005-0156 SBIR Phase I$63,000
Federal grant· 2 of 2 same dayDepartment of Defense · Phase I · Innovative concept for detection and identification of biological toxins$147,976
Federal grantDepartment of Health and Human Services · Phase II · Highly-sensitive zika and dengue antigen/antibody combo test for the point of care$221,653
Federal grantDepartment of Health and Human Services · Phase II · An HIV Viral Load Assay for the Point-Of-Care$1
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
555KAER BIOTHERAPEUTICS CORPORATION$66K—
556PLENOPTIKA, INC.$65K$50K
557PHOTOSOUND TECHNOLOGIES, INC.$65K—
558DAKTARI DIAGNOSTICS, INC.$63K$34M
559Global Cooling, Inc.$61K$3.2M
560Cytocybernetics$61K—
561O.N. DIAGNOSTICS, LLC$61K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Thierry BernardDirector
  • Michael CrowleyExecutive Officer
  • Christopher EarlDirector
  • Donald HawthorneDirector · Executive Officer
  • Peter KasparDirector
  • Roger KittermanDirector
  • Stanley LapidusDirector
  • Edward RobertsDirector
  • William RodriguezDirector · Executive Officer
  • David RubinDirector
  • Aaron SandoskiDirector

Patents

USPTO · 3 granted of 20
  • Counting Particles Using An Electrical Differential Countergranted
  • Microfluidic Metering of Fluidsapplication
  • Microfluidic Metering Of Fluidsgranted
  • Fluid Delivery Devices, Systems, and Methodsapplication
  • Methods For Determining Analytes In Fluidsapplication
  • Fluid Delivery Devices, Systems, And Methodsgranted
  • Mesh Microfluidic Mixing Chamberapplication
  • Fluid Delivery Devices, Systems, And Methodsapplication
  • Methods For Determining Analytes In Fluidsapplication
  • Fluid Delivery Devices, Systems, And Methodsapplication
  • Methods For Determining Analytes In Fluidsapplication
  • Devices And Methods For Determining Analytes In Fluidsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.